<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Jan. 8, 2020 (HealthDay News) — For women with rheumatoid arthritis (RA), adherence to an ideal clinical pathway during pregnancy is associated with a reduced risk for miscarriage and complicated birth, according to a study published online Jan. 7 in Arthritis Care & Research<\/i>.<\/p>\n
Alessandra Bortoluzzi, M.D., Ph.D., from the University of Ferrara in Italy, and colleagues examined the relationship between seven health care quality indicators (HCQI) and adverse pregnancy outcomes (APO; complicated birth or miscarriage). Data were included from first pregnancies in 443 women with RA and 6,097 women from the general population (controls).<\/p>\n
The researchers found that among patients with RA, compared with those who did not follow the ideal pathway, those who followed the ideal pathway had a reduced risk for overall APO (odds ratio, 0.60; 95 percent confidence interval, 0.39 to 0.94) and miscarriage\/perinatal death (odds ratio, 0.40; 95 percent confidence interval, 0.24 to 0.69). Compared with the general population, patients with RA who met all HCQI during pregnancy had similar risks for APO (odds ratio, 0.92; 95 percent confidence interval, 0.61 to 1.38) and miscarriage\/perinatal death (odds ratio, 0.77; 95 percent confidence interval, 0.47 to 1.29).<\/p>\n
“Our findings suggest the adherence to an ideal clinical pathway should be strived for as much as possible in order to offer the best possible chances for a successful pregnancy to women with RA,” the authors write.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n